PRKAA1 and Sepsis: Previous studies, including our own, have shown benefits of pre-emptive administration of AMPK activators in sepsis, including recent studies related to autophagy and mitochondrial biogenesis impairment in age-dependent liver injury, or cardiovascular complications in experimental models50,51.